Home › Epilepsy

Epilepsy clinical trials recruiting in the U.S.

98 studies for Epilepsy are recruiting participants at sites across the United States.

Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.

Cities with the most studies

• Boston, MA19 studies
• Houston, TX16 studies
• New York City, NY13 studies
• Washington, DC12 studies
• Philadelphia, PA11 studies
• Cleveland, OH9 studies
• Phoenix, AZ9 studies
• Durham, NC8 studies
• Rochester, MN8 studies
• Birmingham, AL7 studies
• Mountain View, CA7 studies
• St. Louis, MO7 studies
• Miami, FL7 studies
• Nashville, TN6 studies
• Los Angeles, CA6 studies
• Jacksonville, FL6 studies
• Aurora, CO5 studies
• Chicago, IL5 studies
• Cincinnati, OH5 studies
• Charlotte, NC5 studies
• Dallas, TX4 studies
• Minneapolis, MN4 studies
• Pittsburgh, PA4 studies
• Baltimore, MD4 studies
• Orange, CA4 studies
• Boise, ID4 studies
• Ann Arbor, MI4 studies
• Columbus, OH4 studies
• Clifton, NJ4 studies
• Detroit, MI4 studies
• Akron, OH3 studies
• San Diego, CA3 studies
• New Haven, CT3 studies
• Kansas City, KS3 studies
• Sacramento, CA3 studies
• Salt Lake City, UT3 studies
• Tampa, FL3 studies
• San Francisco, CA3 studies
• Tucson, AZ3 studies
• Atlanta, GA3 studies

By state

• Alabama9 studies
• Arizona10 studies
• Arkansas4 studies
• California20 studies
• Colorado6 studies
• Connecticut3 studies
• Florida13 studies
• Georgia4 studies
• Idaho4 studies
• Illinois7 studies
• Kansas3 studies
• Maryland15 studies
• Massachusetts22 studies
• Michigan9 studies
• Minnesota10 studies
• Missouri8 studies
• New Hampshire6 studies
• New Jersey4 studies
• New York17 studies
• North Carolina11 studies
• Ohio17 studies
• Oregon3 studies
• Pennsylvania13 studies
• Tennessee7 studies
• Texas21 studies
• Utah3 studies
• Virginia3 studies
• Washington3 studies
• Wisconsin3 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.